China Meheco Group Co., Ltd. (SHA:600056)
10.33
-0.04 (-0.39%)
May 8, 2026, 3:00 PM CST
China Meheco Group Revenue
China Meheco Group had revenue of 8.19B CNY in the quarter ending March 31, 2026, a decrease of -0.90%. This brings the company's revenue in the last twelve months to 35.02B, up 0.08% year-over-year. In the year 2025, China Meheco Group had annual revenue of 35.36B with 3.55% growth.
Revenue (ttm)
35.02B
Revenue Growth
+0.08%
P/S Ratio
0.44
Revenue / Employee
4.19M
Employees
8,368
Market Cap
15.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.36B | 1.21B | 3.55% |
| Dec 31, 2024 | 34.15B | -4.68B | -12.04% |
| Dec 31, 2023 | 38.82B | 1.23B | 3.28% |
| Dec 31, 2022 | 37.59B | 1.36B | 3.75% |
| Dec 31, 2021 | 36.23B | -3.08B | -7.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 288.08B |
| Jointown Pharmaceutical Group | 164.16B |
| C.Q. Pharmaceutical Holding | 82.27B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 78.46B |
| China National Accord Medicines Corporation | 72.95B |
| China National Medicines Corporation | 53.31B |
| Guangxi LiuYao Group | 20.99B |
| Liaoning Cheng Da | 9.43B |